Regulation of HIV-1 and related lentiviruses by the DNA damage response
DNA 损伤反应对 HIV-1 和相关慢病毒的调节
基本信息
- 批准号:9204186
- 负责人:
- 金额:$ 16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-02 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAddressAffectAntiviral AgentsBiochemistryBiologyCRISPR/Cas technologyCell Cycle ArrestCellsCharacteristicsComplexConflict (Psychology)DNADNA DamageDNA RepairDataDeoxyribonuclease IDeveloping CountriesEnvironmentEvolutionFamilyFoundationsFundingGene ExpressionGenesGoalsHIVHIV-1HealthHomeostasisHumanHuman BiologyImmune responseInfectionIntegration Host FactorsKnowledgeLightMolecularMolecular BiologyMolecular VirologyNaturePathogenesisPathway interactionsPrimate LentivirusesPrimatesProteinsRNARecording of previous eventsRecruitment ActivityRegulationResearchResearch Project GrantsRoleSignaling ProteinStructureSubfamily lentivirinaeTestingUnderserved PopulationVariantViralViral ProteinsVirusWorkcofactorfight againstfollow-upin vivointerdisciplinary approachnovelpandemic diseasepathogenresearch studyresponsesuccessubiquitin ligaseviral transmissionvirus host interactionvpr Gene Productsvpr Genes
项目摘要
PROJECT SUMMARY/ABSTRACT
HIV presents a major obstacle to human health, particularly in developing nations. The success of HIV is
largely due to its ability to adapt to the human host environment and circumvent our innate immune responses.
This is principally achieved through viral accessory proteins, which engage cellular proteins to both antagonize
host antiviral factors and usurp host cellular machinery. The understanding of these interactions is critical to
our fight against HIV. My proposal will determine how cellular proteins involved in the DNA damage response
interact with HIV and related lentiviruses to modulate their lifecycle. I hypothesize that the DNA damage
response is both anti-viral and pro-viral, as this protein-signaling cascade can sense aberrant DNA and RNA
structures and can directly affect cellular homeostasis.
HIV belongs to a family of viruses called lentiviruses that infect at least 40 primate species, including
humans. Using the natural variation present in lentiviruses, I will determine how Vpr, a viral accessory protein
that is common to all extant lentiviruses, has evolved to engage the host DNA damage response through both
activation of DNA damage response pathways and direct interactions with DNA damage response proteins. I
will specifically test the hypothesis that Vpr directly causes DNA damage in order to activate this cellular
response. Furthermore, I will determine if engagement with the DNA damage response is a conserved, and
therefore important, function for all lentiviruses, or if it is specific to HIV-1, and thus critical for adaptations and
pathogenesis in humans.
In addition, I will expand our knowledge of the role of the DNA damage response in lentiviral biology by
identifying novel regulators of HIV-1 that are also involved in this cellular response. I will perform an evolution-
guided screen to identify candidate DNA damage response proteins and pathways, and I will follow up these
hits with specific experiments to elucidate their roles. These studies will identify the DNA damage response as
important regulators of HIV-1 and related lentiviruses. They will shed light on lentiviral evolution, on the cellular
response to infection, and on the multifaceted roles of the DNA damage response, while helping to identify
potential antiviral targets in our fight against HIV.
项目总结/摘要
艾滋病毒是人类健康的主要障碍,特别是在发展中国家。艾滋病毒的成功是
这主要是由于它能够适应人类宿主环境并规避我们的先天免疫反应。
这主要是通过病毒辅助蛋白来实现的,该蛋白与细胞蛋白结合,
宿主抗病毒因子和篡夺宿主细胞机制。理解这些相互作用对于
我们与艾滋病的斗争。我的建议将确定细胞蛋白如何参与DNA损伤反应
与HIV和相关慢病毒相互作用以调节它们的生命周期。我假设DNA损伤
反应既是抗病毒的,又是促病毒的,因为这种蛋白质信号级联可以检测异常的DNA和RNA
结构,并可直接影响细胞内稳态。
HIV属于一个称为慢病毒的病毒家族,感染至少40种灵长类动物,包括
人类利用慢病毒中存在的自然变异,我将确定病毒辅助蛋白Vpr
所有现存的慢病毒都有,已经进化到通过两种途径参与宿主DNA损伤反应,
DNA损伤反应途径的激活以及与DNA损伤反应蛋白的直接相互作用。我
我将专门测试Vpr直接导致DNA损伤的假设,以激活这种细胞,
反应此外,我将确定参与DNA损伤反应是否是保守的,
因此重要的是,它对所有慢病毒都有功能,或者它对HIV-1有特异性,因此对适应和
人类的发病机制。
此外,我将通过以下方式扩展我们对DNA损伤反应在慢病毒生物学中的作用的认识:
确定新的HIV-1调节因子,它们也参与了这种细胞反应。我要进行进化-
引导筛选,以确定候选DNA损伤反应蛋白和途径,我将跟进这些
点击具体的实验来阐明他们的作用。这些研究将确定DNA损伤反应,
HIV-1和相关慢病毒的重要调节因子。他们将阐明慢病毒的进化,
对感染的反应,以及DNA损伤反应的多方面作用,同时帮助识别
潜在的抗病毒靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oliver I Fregoso其他文献
Oliver I Fregoso的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oliver I Fregoso', 18)}}的其他基金
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
人脑类器官中 HIV 相关神经认知障碍的综合建模
- 批准号:
10055749 - 财政年份:2020
- 资助金额:
$ 16万 - 项目类别:
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
人脑类器官中 HIV 相关神经认知障碍的综合建模
- 批准号:
10224904 - 财政年份:2020
- 资助金额:
$ 16万 - 项目类别:
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
人脑类器官中 HIV 相关神经认知障碍的综合建模
- 批准号:
10403665 - 财政年份:2020
- 资助金额:
$ 16万 - 项目类别:
Integrative Modeling of HIV-Associated Neurocognitive Disorder in Human Brain Organoids
人脑类器官中 HIV 相关神经认知障碍的综合建模
- 批准号:
10619582 - 财政年份:2020
- 资助金额:
$ 16万 - 项目类别:
Defining the regulation of double-strand DNA break repair by HIV Vpr
定义 HIV Vpr 对双链 DNA 断裂修复的调节
- 批准号:
10391452 - 财政年份:2019
- 资助金额:
$ 16万 - 项目类别:
Defining the regulation of double-strand DNA break repair by HIV Vpr
定义 HIV Vpr 对双链 DNA 断裂修复的调节
- 批准号:
10615655 - 财政年份:2019
- 资助金额:
$ 16万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16万 - 项目类别:
Research Grant














{{item.name}}会员




